Ajanta Pharma Q4FY21 consolidated PAT drops QoQ to Rs. 159.26 Cr
Chemical

Ajanta Pharma Q4FY21 consolidated PAT drops QoQ to Rs. 159.26 Cr

The companyreported total income of Rs.2915.67 crores during the 12 months period ended March 31, 2021

  • By ICN Bureau | May 03, 2021

Ajanta Pharma has reported total income of Rs.759.37 crores during the period ended March 31, 2021 as compared to Rs.754.22 crores during the period ended December 31, 2020 and a total income of Rs.738.65 crores during the period ended March 31, 2020.

Ajanta Pharma has posted net profit of Rs.159.26 crores for the period ended March 31, 2021 as against net profit of Rs.176.63 crores for the period ended December 31, 2020 and Rs.129.16 crores for the period ended March 31, 2020.

Ajanta Pharma has reported total income of Rs.2915.67 crores during the 12 months period ended March 31, 2021 as compared to Rs.2680.06 crores during the 12 months period ended March 31, 2020.

Ajanta Pharma has posted net profit / (loss) of Rs.653.87 crores for the 12 months period ended March 31, 2021 as against net profit / (loss) of Rs.467.70 crores for the 12 months period ended March 31, 2020.

Register Now to Attend NextGen Chemicals & Petrochemicals Summit 2024, 11-12 July 2024, Mumbai

Other Related stories

Startups

Petrochemical

Energy

Digitization